Related references
Note: Only part of the references are listed.Targeting miR-21 to Treat Psoriasis
Juan Guinea-Viniegra et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Cathepsin K Is Involved in Development of Psoriasis-like Skin Lesions through TLR-Dependent Th17 Activation
Toshitake Hirai et al.
JOURNAL OF IMMUNOLOGY (2013)
Normal CFTR Inhibits Epidermal Growth Factor Receptor-Dependent Pro-Inflammatory Chemokine Production in Human Airway Epithelial Cells
Suil Kim et al.
PLOS ONE (2013)
The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses
Michelle A. Lowes et al.
TRENDS IN IMMUNOLOGY (2013)
A case of rapid improvement of severe psoriasis during molecular-targeted therapy using an epidermal growth factor receptor tyrosine kinase inhibitor for metastatic lung adenocarcinoma
Noritaka Oyama et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEAL
Kenneth Gordon et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behcet's disease
Sunao Sugita et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Distinct Roles of IL-23 and IL-17 in the Development of Psoriasis-Like Lesions in a Mouse Model
Kimiko Nakajima et al.
JOURNAL OF IMMUNOLOGY (2011)
Th17 Cells Induce Colitis and Promote Th1 Cell Responses through IL-17 Induction of Innate IL-12 and IL-23 Production
Ting Feng et al.
JOURNAL OF IMMUNOLOGY (2011)
EGFR and IL-1 Signaling Synergistically Promote Keratinocyte Antimicrobial Defenses in a Differentiation-Dependent Manner
Andrew Johnston et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Stat3 as a Therapeutic Target for the Treatment of Psoriasis: A Clinical Feasibility Study with STA-21, a Stat3 Inhibitor
Ken Miyoshi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Inflammatory Skin and Bowel Disease Linked to ADAM17 Deletion
Diana C. Blaydon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17
Thorsten Maretzky et al.
NATURE COMMUNICATIONS (2011)
MicroRNAs and potential target interactions in psoriasis
John R. Zibert et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2010)
TRIF Signaling Stimulates Translation of TNF-α mRNA via Prolonged Activation of MK2
Petra Gais et al.
JOURNAL OF IMMUNOLOGY (2010)
Metalloproteinase-Mediated, Context-Dependent Function of Amphiregulin and HB-EGF in Human Keratinocytes and Skin
Stefan W. Stoll et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Amphiregulin Carboxy-Terminal Domain Is Required for Autocrine Keratinocyte Growth
Stefan W. Stoll et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
STAT3 Activation of miR-21 and miR-181b-1 via PTEN and CYLD Are Part of the Epigenetic Switch Linking Inflammation to Cancer
Dimitrios Iliopoulos et al.
MOLECULAR CELL (2010)
The prostaglandin receptor EP2 activates multiple signaling pathways and β-arrestin1 complex formation during mouse skin papilloma development
Kyung-Soo Chun et al.
CARCINOGENESIS (2009)
Complete remission of psoriasis following bevacizumab therapy for colon cancer
A. Akman et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2009)
TNFα shedding and epidermal inflammation are controlled by Jun proteins
Juan Guinea-Viniegra et al.
GENES & DEVELOPMENT (2009)
Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes
Lisa C. Zaba et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
HB-EGF-induced VEGF production and eNOS activation depend on both PI3 kinase and MAP kinase in HaCaT cells
Kozo Nakai et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2009)
Cetuximab Treatment in a Patient with Metastatic Colorectal Cancer and Psoriasis
Bart Neyns et al.
Current Oncology (2008)
Impact of Stat3 activation upon skin biology: A dichotomy of its role between homeostasis and diseases
Shigetoshi Sano et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2008)
Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses
Lisa C. Zaba et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Involvement of tumor necrosis factor (TNF)-α in phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced skin edema in mice
M Murakawa et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Innate and adaptive immunity and the pathophysiology of psoriasis
AA Gaspari
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Protein expression of TNF-α in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2
C Johansen et al.
JOURNAL OF IMMUNOLOGY (2006)
TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques
AB Gottlieb et al.
JOURNAL OF IMMUNOLOGY (2005)
Signal transducer and activator of transcription 3 is a key regulator of keratinocyte survival and proliferation following UV irradiation
S Sano et al.
CANCER RESEARCH (2005)
Overexpression of tumour necrosis factor-α-converting enzyme in psoriasis
M Kawaguchi et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model
S Sano et al.
NATURE MEDICINE (2005)
Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis
KS Chan et al.
CANCER RESEARCH (2004)
Localization of tumour necrosis factor-α converting enzyme in normal human skin
M Kawaguchi et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2004)
Abnormal TNF activity in Timp3-/- mice leads to chronic hepatic inflammation and failure of liver regeneration
FF Mohammed et al.
NATURE GENETICS (2004)
Vascular endothelial growth factor: Basic science and clinical progress
N Ferrara
ENDOCRINE REVIEWS (2004)
Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis
YP Xia et al.
BLOOD (2003)
The C-terminal domains of TACE weaken the inhibitory action of N-TIMP-3
MH Lee et al.
FEBS LETTERS (2002)
Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing
S Tokumaru et al.
JOURNAL OF CELL BIOLOGY (2000)
Share Paper
